Akero Therapeutics, Inc. (AKRO)
Total Valuation
AKRO has a market cap or net worth of $1.30 billion. The enterprise value is $771.82 million.
| Market Cap | 1.30B |
| Enterprise Value | 771.82M |
Important Dates
The last earnings date was Monday, November 13, 2023, before market open.
| Earnings Date | Nov 13, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
AKRO has 55.71 million shares outstanding. The number of shares has increased by 43.84% in one year.
| Shares Outstanding | 55.71M |
| Shares Change (YoY) | +43.84% |
| Shares Change (QoQ) | +7.22% |
| Owned by Insiders (%) | 6.88% |
| Owned by Institutions (%) | 103.80% |
| Float | 48.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.23 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.25, with a Debt / Equity ratio of 0.04.
| Current Ratio | 20.25 |
| Quick Ratio | n/a |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -45.66 |
Financial Efficiency
Return on equity (ROE) is -26.10% and return on invested capital (ROIC) is -22.41%.
| Return on Equity (ROE) | -26.10% |
| Return on Assets (ROA) | -23.90% |
| Return on Capital (ROIC) | -22.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.35M |
| Employee Count | 51 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.64% in the last 52 weeks. The beta is -0.51, so AKRO's price volatility has been lower than the market average.
| Beta (1Y) | -0.51 |
| 52-Week Price Change | -56.64% |
| 50-Day Moving Average | 17.03 |
| 200-Day Moving Average | 37.41 |
| Relative Strength Index (RSI) | 63.06 |
| Average Volume (30 Days) | 2,010,230 |
Short Selling Information
The latest short interest is 6.56 million, so 11.77% of the outstanding shares have been sold short.
| Short Interest | 6.56M |
| Short Previous Month | 6.37M |
| Short % of Shares Out | 11.77% |
| Short % of Float | 13.40% |
| Short Ratio (days to cover) | 4.81 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -136.42M |
| Pretax Income | -119.63M |
| Net Income | -119.63M |
| EBITDA | -116.80M |
| EBIT | -117.07M |
| Earnings Per Share (EPS) | -$2.28 |
Balance Sheet
The company has $554.73 million in cash and $25.73 million in debt, giving a net cash position of $529.00 million or $9.50 per share.
| Cash & Cash Equivalents | 554.73M |
| Total Debt | 25.73M |
| Net Cash | 529.00M |
| Net Cash Per Share | $9.50 |
| Equity / Book Value | 583.14M |
| Book Value Per Share | 10.47 |
| Working Capital | 547.53M |
Cash Flow
| Operating Cash Flow | -122.25M |
| Capital Expenditures | n/a |
| Free Cash Flow | -122.25M |
| FCF Per Share | -$2.20 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AKRO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -9.20% |
| FCF Yield | -9.40% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.84% |
| Shareholder Yield | -43.84% |
Analyst Forecast
The average price target for AKRO is $44.43, which is 90.28% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.43 |
| Price Target Difference | 90.28% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |